跳至主要内容
临床试验/NCT03942497
NCT03942497已完成不适用

Clinical-pathological Characterization and Outcomes of Metastatic Urothelial Cancer in Latin America: Retrospective and Translational Multicenter Database

Latin American Cooperative Oncology Group9 个研究点 分布在 1 个国家目标入组 218 人开始时间: 2019年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
218
试验地点
9
主要终点
Epidemiology

研究概览

简要总结

The LACOG 1518 study will characterize demographic and clinical-pathological profile of patients diagnosed with recurrent/ metastatic urothelial cancer in Latin America.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age at least 18 years;
  • Histological confirmation of urothelial carcinoma (include mixed urothelial histology);
  • Diagnosis of recurrent or metastatic (Stage IV) urothelial carcinoma during the period of January 2016 to July 2018;
  • Site and investigator ability to collect adequate patient characteristics, treatment and outcome data from medical records;
  • Availability of tumor sample (FFPE/slides) from primary tumor or metastatic site at the time of registration.

排除标准

  • Synchronous tumors or history of other malignancy in the previous 3 years before study entry (exception to non-melanoma skin cancer or non-invasive cancers);
  • Pure non-urothelial carcinoma histology.

结局指标

主要结局

Epidemiology

时间窗: 2 years

Overall survival (OS) will be defined from the date of treatment initiation to date of death from any cause. In case of patients that received palliative care only, OS will be defined from date of diagnosis of advanced disease to date of death from any cause. Patients who are alive will be censored at the date of last known contact.

次要结局

  • Socioeconomic chactacteristcs(2 years)
  • Overall response(2 years)
  • PFS(2 years)
  • Duration of response(2 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (9)

Loading locations...

相似试验